7KPU image
Deposition Date 2020-11-12
Release Date 2021-06-16
Last Version Date 2023-10-18
Entry Detail
PDB ID:
7KPU
Keywords:
Title:
Crystal structure of human NatD (NAA40) bound to a bisubstrate analogue with a C-3 linker
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.43 Å
R-Value Free:
0.18
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:N-alpha-acetyltransferase 40
Gene (Uniprot):NAA40
Chain IDs:A (auth: D), C (auth: A)
Chain Length:204
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:bisubstrate analogue (CMC-ACE-SER-GLY-ARG-GLY-LYS)
Chain IDs:B (auth: E), D (auth: B)
Chain Length:5
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.
J.Med.Chem. 64 8263 8271 (2021)
PMID: 34110812 DOI: 10.1021/acs.jmedchem.1c00141

Abstact

Protein N-terminal acetyltransferase D (NatD, NAA40) that specifically acetylates the alpha-N-terminus of histone H4 and H2A has been implicated in various diseases, but no inhibitor has been reported for this important enzyme. Based on the acetyl transfer mechanism of NatD, we designed and prepared a series of highly potent NatD bisubstrate inhibitors by covalently linking coenzyme A to different peptide substrates via an acetyl or propionyl spacer. The most potent bisubstrate inhibitor displayed an apparent Ki value of 1.0 nM. Biochemical studies indicated that bisubstrate inhibitors are competitive to the peptide substrate and noncompetitive to the cofactor, suggesting that NatD undergoes an ordered Bi-Bi mechanism. We also demonstrated that these inhibitors are highly specific toward NatD, displaying about 1000-fold selectivity over other closely related acetyltransferases. High-resolution crystal structures of NatD bound to two of these inhibitors revealed the molecular basis for their selectivity and inhibition mechanism, providing a rational path for future inhibitor development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures